Clinical Trials Logo

Clinical Trial Summary

This study is to find a safe dose of the combination of Avelumab and Whole Brain Radiotherapy (WBRT) in patients with Leptomeningeal Disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03719768
Study type Interventional
Source H. Lee Moffitt Cancer Center and Research Institute
Contact
Status Active, not recruiting
Phase Phase 1
Start date June 10, 2019
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT01438021 - Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease N/A
Completed NCT02616393 - Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases Phase 2
Completed NCT03101579 - Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer Phase 1
Not yet recruiting NCT06462092 - Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer Phase 1/Phase 2
Terminated NCT00005812 - Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Phase 2
Terminated NCT03661424 - BATs in Patients With Breast Cancer and Leptomeningeal Metastases Phase 1
Active, not recruiting NCT05289908 - Intrathecal Pemetrexed for Leptomeningeal Metastasis Phase 1/Phase 2
Recruiting NCT05184816 - A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis Phase 1
Not yet recruiting NCT03613181 - ANG1005 in Leptomeningeal Disease From Breast Cancer Phase 3
Terminated NCT03275402 - 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases Phase 2/Phase 3
Completed NCT01645839 - Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer Phase 3
Completed NCT03520504 - Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases Phase 1
Completed NCT00992602 - Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Phase 2
Completed NCT00005811 - Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment Phase 2
Active, not recruiting NCT04343573 - Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors Phase 2